-+ 0.00%
-+ 0.00%
-+ 0.00%

RECURSION PHARMACEUTICALS - MODIFIED SPIGELMAN STAGE PROGRESSION AND POLYP BURDEN INCLUDED AS SECONDARY ENDPOINTS

Reuters·11/18/2026 10:01:07